Home

search

Subjectguide
Journals
Books / Serials / Multimedia
Services
Services

Login for Subscribers
Logout

Sitemap
Help
Contacts


Logo






Vol. 20, No. 4, 2005   

Free Abstract     Article (Fulltext)     Article (PDF 108 KB)     

Review

Neuron-Specific Enolase as a Marker for Acute Ischemic Stroke: A Systematic Review
Nishant Ananda, b, Latha G. Steada

aDepartment of Emergency Medicine, Mayo Clinic, and
bStudent, Mayo Medical School, Mayo Clinic College of Medicine, Rochester, Minn., USA

Address of Corresponding Author

Cerebrovasc Dis 2005;20:213-219 (DOI: 10.1159/000087701)


 goto top of page Key Words

  • Neuron-specific enolase
  • Serum marker
  • Stroke

 goto top of page Abstract

Background: To date, most work delineating the usefulness of neuron-specific enolase (NSE) as a marker for acute ischemic stroke has been inconclusive. This study had the following objectives: (1) to determine whether serum concentrations of NSE correlate with time of onset of stroke symptoms, volume of infarcted tissue, stroke severity, functional outcome, or length of hospital stay; (2) to determine whether serial measurements of NSE levels are useful markers for ongoing brain ischemia, and (3) to determine whether NSE levels at various time intervals are significantly higher in patients with stroke than in controls. Methods: All abstracts and published full reports identified as potentially relevant by the literature search were independently assessed for inclusion in the review by each reviewer. Twelve studies (including 597 patients) satisfied the entry criteria for this qualitative analysis. Results: In 4 studies, time of onset of stroke symptoms was compared with time of first detectable NSE levels, which ranged from 4 to 8 h after stroke onset. In 7 studies, NSE levels increased with increased size of stroke, but in 2 studies there was no correlation. In the 2 studies that compared stroke severity with NSE levels, high NSE levels generally indicated worse outcome, but at low NSE levels the results were equivocal. In 7 studies, functional outcome at hospital dismissal and follow-up was compared with NSE levels; in 4, there was no correlation. Conclusions: The serum level of NSE does seem to be higher in stroke patients than in controls, and it does appear to correlate with volume of infarcted tissue. However, it does not appear to correlate with functional outcome, and its relationship to stroke severity is unclear. This may be explained at least in part by the disparity in sampling times because the NSE level has been shown to peak after 24 h in most studies. Hence, the more delayed the sampling, the greater the correlation with stroke severity.

Copyright © 2005 S. Karger AG, Basel


 goto top of page Author Contacts

Latha G. Stead, MD
Department of Emergency Medicine, Mayo Clinic
200 First Street SW
Rochester, MN 55905 (USA)


 goto top of page Article Information

Received: June 21, 2004
Accepted: April 29, 2005
Published online: August 22, 2005
Number of Print Pages : 7
Number of Figures : 0, Number of Tables : 1, Number of References : 18

 
Journal Home
Journal Content
Guidelines
Editorial Board
Aims and Scope
Subscriptions
Medline Abstract (ID 16123539)
Download Citation
Cited In



This journal is part of the first subject package of the Karger

Journal Archive Collection

Information on packages (PDF)
Free sample issues

Case Reports in Neurology


For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service.




copyright  © 2009 S. Karger AG, Basel